Total Funding
56
56
Total FundingGrant raised
Growth Score
-3 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
77997
Kalion is a biotech company that manufactures high-purity chemicals for the pharmaceutical markets.
Alan Watson: Vice President of DevelopmentPast Role: Elixir Pharmaceuticals, Executive Vice President & Chief Business Officer
Darcy Prather: PresidentPast Role: Beta Data Services Inc., Vice President of Strategy
About the Company
Kalion is an early stage industrial biotech company that will transform the traditional chemical industry by providing low-cost access to glucaric acid and S-3-hydroxybutyrolactone (3-HBL) using traditional, green, fermentation technology. Glucaric acid and 3-HBL were identified as “Top Value Added Chemicals from Biomass” and multi-billion dollar
markets for use of the two chemicals are limited by cost and availability (2004 DOE report).
Women Founded
